Table of Contents

1 Study Coverage

• 1.1 Kidney Cancer Diagnosis Product Introduction
• 1.2 Global Kidney Cancer Diagnosis Outlook 2017 VS 2022 VS 2028
  • 1.2.1 Global Kidney Cancer Diagnosis Sales in US$ Million for the Year 2017-2028
  • 1.2.2 Global Kidney Cancer Diagnosis Sales in Volume for the Year 2017-2028
• 1.3 United States Kidney Cancer Diagnosis Outlook 2017 VS 2022 VS 2028
  • 1.3.1 United States Kidney Cancer Diagnosis Sales in US$ Million for the Year 2017-2028
  • 1.3.2 United States Kidney Cancer Diagnosis Sales in Volume for the Year 2017-2028
• 1.4 Kidney Cancer Diagnosis Market Size, United States VS Global, 2017 VS 2022 VS 2028
  • 1.4.1 The Market Share of United States Kidney Cancer Diagnosis in Global, 2017 VS 2022 VS 2028
  • 1.4.2 The Growth Rate of Kidney Cancer Diagnosis Market Size, United States VS Global, 2017 VS 2022 VS 2028
• 1.5 Kidney Cancer Diagnosis Market Dynamics
  • 1.5.1 Kidney Cancer Diagnosis Industry Trends
  • 1.5.2 Kidney Cancer Diagnosis Market Drivers
  • 1.5.3 Kidney Cancer Diagnosis Market Challenges
  • 1.5.4 Kidney Cancer Diagnosis Market Restraints
• 1.6 Study Objectives
• 1.7 Years Considered

2 Market by Type

• 2.1 Kidney Cancer Diagnosis Market Segment by Type
  • 2.1.1 Immunohistochemical Test
  • 2.1.2 Complete Blood Count Test
  • 2.1.3 Urine Test
  • 2.1.4 Blood Chemistry Test
• 2.2 Global Kidney Cancer Diagnosis Market Size by Type
  • 2.2.1 Global Kidney Cancer Diagnosis Sales in Value, by Type (2017, 2022 & 2028)
  • 2.2.2 Global Kidney Cancer Diagnosis Sales in Volume, by Type (2017, 2022 & 2028)
  • 2.2.3 Global Kidney Cancer Diagnosis Average Selling Price (ASP) by Type (2017, 2022 & 2028)
• 2.3 United States Kidney Cancer Diagnosis Market Size by Type
  • 2.3.1 United States Kidney Cancer Diagnosis Sales in Value, by Type (2017, 2022 & 2028)
  • 2.3.2 United States Kidney Cancer Diagnosis Sales in Volume, by Type (2017, 2022 & 2028)
  • 2.3.3 United States Kidney Cancer Diagnosis Average Selling Price (ASP) by Type (2017, 2022 & 2028)

3 Market by Application

• 3.1 Kidney Cancer Diagnosis Market Segment by Application
  • 3.1.1 Hospital
  • 3.1.2 Surgery Center
• 3.2 Global Kidney Cancer Diagnosis Market Size by Application
  • 3.2.1 Global Kidney Cancer Diagnosis Sales in Value, by Application (2017, 2022 & 2028)
  • 3.2.2 Global Kidney Cancer Diagnosis Sales in Volume, by Application (2017, 2022 & 2028)
  • 3.3.3 Global Kidney Cancer Diagnosis Average Selling Price (ASP) by Application (2017, 2022 & 2028)
• 3.3 United States Kidney Cancer Diagnosis Market Size by Application
  • 3.3.1 United States Kidney Cancer Diagnosis Sales in Value, by Application (2017, 2022 & 2028)
  • 3.3.2 United States Kidney Cancer Diagnosis Sales in Volume, by Application (2017, 2022 & 2028)
  • 3.3.3 United States Kidney Cancer Diagnosis Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global Kidney Cancer Diagnosis Competitor Landscape by Company

• 4.1 Global Kidney Cancer Diagnosis Market Size by Company
  • 4.1.1 Top Global Kidney Cancer Diagnosis Manufacturers Ranked by Revenue (2021)
  • 4.1.2 Global Kidney Cancer Diagnosis Revenue by Manufacturer (2017-2022)
  • 4.1.3 Global Kidney Cancer Diagnosis Sales by Manufacturer (2017-2022)
  • 4.1.4 Global Kidney Cancer Diagnosis Price by Manufacturer (2017-2022)
• 4.2 Global Kidney Cancer Diagnosis Concentration Ratio (CR)
  • 4.2.1 Kidney Cancer Diagnosis Market Concentration Ratio (CR) (2017-2022)
  • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Kidney Cancer Diagnosis in 2021
  • 4.2.3 Global Kidney Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.3 Global Kidney Cancer Diagnosis Manufacturing Base Distribution, Product Type
  • 4.3.1 Global Kidney Cancer Diagnosis Manufacturers, Headquarters and Distribution of Producing Region
  • 4.3.2 Manufacturers Kidney Cancer Diagnosis Product Type
  • 4.3.3 Date of International Manufacturers Enter into Kidney Cancer Diagnosis Market
• 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
• 4.5 United States Kidney Cancer Diagnosis Market Size by Company
  • 4.5.1 Top Kidney Cancer Diagnosis Players in United States, Ranked by Revenue (2021)
  • 4.5.2 United States Kidney Cancer Diagnosis Revenue by Players (2020, 2021 & 2022)
  • 4.5.3 United States Kidney Cancer Diagnosis Sales by Players (2020, 2021 & 2022)

5 Global Kidney Cancer Diagnosis Market Size by Region

• 5.1 Global Kidney Cancer Diagnosis Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Kidney Cancer Diagnosis Market Size in Volume by Region (2017-2028)
  • 5.2.1 Global Kidney Cancer Diagnosis Sales in Volume by Region: 2017-2022
  • 5.2.2 Global Kidney Cancer Diagnosis Sales in Volume Forecast by Region (2023-2028)
• 5.3 Global Kidney Cancer Diagnosis Market Size in Value by Region (2017-2028)
  • 5.3.1 Global Kidney Cancer Diagnosis Sales in Value by Region: 2017-2022
  • 5.3.2 Global Kidney Cancer Diagnosis Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level

• 6.1 North America
  • 6.1.1 North America Kidney Cancer Diagnosis Market Size YoY Growth 2017-2028
  • 6.1.2 North America Kidney Cancer Diagnosis Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.1.3 United States
  • 6.1.4 Canada
• 6.2 Asia-Pacific
  • 6.2.1 Asia-Pacific Kidney Cancer Diagnosis Market Size YoY Growth 2017-2028
  • 6.2.2 Asia-Pacific Kidney Cancer Diagnosis Market Facts & Figures by Region (2017, 2022 & 2028)
  • 6.2.3 China
  • 6.2.4 Japan
  • 6.2.5 South Korea
  • 6.2.6 India
  • 6.2.7 Australia
  • 6.2.8 China Taiwan
  • 6.2.9 Indonesia
  • 6.2.10 Thailand
  • 6.2.11 Malaysia
• 6.3 Europe
  • 6.3.1 Europe Kidney Cancer Diagnosis Market Size YoY Growth 2017-2028
  • 6.3.2 Europe Kidney Cancer Diagnosis Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.3.3 Germany
  • 6.3.4 France
  • 6.3.5 U.K.
  • 6.3.6 Italy
  • 6.3.7 Russia
• 6.4 Latin America
  • 6.4.1 Latin America Kidney Cancer Diagnosis Market Size YoY Growth 2017-2028
  • 6.4.2 Latin America Kidney Cancer Diagnosis Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.4.3 Mexico
  • 6.4.4 Brazil
  • 6.4.5 Argentina
  • 6.4.6 Colombia
• 6.5 Middle East and Africa
  • 6.5.1 Middle East and Africa Kidney Cancer Diagnosis Market Size YoY Growth 2017-2028
  • 6.5.2 Middle East and Africa Kidney Cancer Diagnosis Market Facts & Figures by Country (2017, 2022 & 2028)
  • 6.5.3 Turkey
  • 6.5.4 Saudi Arabia
  • 6.5.5 UAE

7 Company Profiles

• 7.1 Myriad Genetics Inc.
  • 7.1.1 Myriad Genetics Inc. Corporation Information
  • 7.1.2 Myriad Genetics Inc. Description and Business Overview
  • 7.1.3 Myriad Genetics Inc. Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2017-2022)
  • 7.1.4 Myriad Genetics Inc. Kidney Cancer Diagnosis Products Offered
  • 7.1.5 Myriad Genetics Inc. Recent Development
• 7.2 NeoGenomics Laboratories
  • 7.2.1 NeoGenomics Laboratories Corporation Information
  • 7.2.2 NeoGenomics Laboratories Description and Business Overview
  • 7.2.3 NeoGenomics Laboratories Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2017-2022)
  • 7.2.4 NeoGenomics Laboratories Kidney Cancer Diagnosis Products Offered
  • 7.2.5 NeoGenomics Laboratories Recent Development
• 7.3 Thermo Fisher Scientific Inc.
  • 7.3.1 Thermo Fisher Scientific Inc. Corporation Information
  • 7.3.2 Thermo Fisher Scientific Inc. Description and Business Overview
  • 7.3.3 Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2017-2022)
  • 7.3.4 Thermo Fisher Scientific Inc. Kidney Cancer Diagnosis Products Offered
  • 7.3.5 Thermo Fisher Scientific Inc. Recent Development
• 7.4 Sysmex Corporation
  • 7.4.1 Sysmex Corporation Corporation Information
  • 7.4.2 Sysmex Corporation Description and Business Overview
  • 7.4.3 Sysmex Corporation Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2017-2022)
  • 7.4.4 Sysmex Corporation Kidney Cancer Diagnosis Products Offered
  • 7.4.5 Sysmex Corporation Recent Development
• 7.5 Rosetta Genomics
  • 7.5.1 Rosetta Genomics Corporation Information
  • 7.5.2 Rosetta Genomics Description and Business Overview
  • 7.5.3 Rosetta Genomics Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2017-2022)
  • 7.5.4 Rosetta Genomics Kidney Cancer Diagnosis Products Offered
  • 7.5.5 Rosetta Genomics Recent Development
• 7.6 Illumina Inc.
  • 7.6.1 Illumina Inc. Corporation Information
  • 7.6.2 Illumina Inc. Description and Business Overview
  • 7.6.3 Illumina Inc. Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2017-2022)
  • 7.6.4 Illumina Inc. Kidney Cancer Diagnosis Products Offered
  • 7.6.5 Illumina Inc. Recent Development
• 7.7 Abbott Laboratories
  • 7.7.1 Abbott Laboratories Corporation Information
  • 7.7.2 Abbott Laboratories Description and Business Overview
  • 7.7.3 Abbott Laboratories Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2017-2022)
  • 7.7.4 Abbott Laboratories Kidney Cancer Diagnosis Products Offered
  • 7.7.5 Abbott Laboratories Recent Development
• 7.8 Roche Holding AG
  • 7.8.1 Roche Holding AG Corporation Information
  • 7.8.2 Roche Holding AG Description and Business Overview
  • 7.8.3 Roche Holding AG Kidney Cancer Diagnosis Sales, Revenue and Gross Margin (2017-2022)
  • 7.8.4 Roche Holding AG Kidney Cancer Diagnosis Products Offered
  • 7.8.5 Roche Holding AG Recent Development

8 Industry Chain and Sales Channels Analysis

• 8.1 Kidney Cancer Diagnosis Industry Chain Analysis
• 8.2 Kidney Cancer Diagnosis Key Raw Materials
  • 8.2.1 Key Raw Materials
  • 8.2.2 Kidney Cancer Diagnosis Distributors
• 8.3 Kidney Cancer Diagnosis Production Mode & Process
• 8.4 Kidney Cancer Diagnosis Sales and Marketing
  • 8.4.1 Kidney Cancer Diagnosis Sales Channels
  • 8.4.2 Kidney Cancer Diagnosis Distributors
• 8.5 Kidney Cancer Diagnosis Customers

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details

Summary:

Market Analysis and Insights: Global and United States Kidney Cancer Diagnosis Market
This report focuses on global and United States Kidney Cancer Diagnosis market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Kidney Cancer Diagnosis market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Immunohistochemical Test accounting for % of the Kidney Cancer Diagnosis global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Kidney Cancer Diagnosis market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Kidney Cancer Diagnosis Scope and Market Size
Kidney Cancer Diagnosis market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Kidney Cancer Diagnosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Kidney Cancer Diagnosis market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Kidney Cancer Diagnosis market is segmented into
Immunohistochemical Test
Complete Blood Count Test
Urine Test
Blood Chemistry Test
Segment by Application, the Kidney Cancer Diagnosis market is segmented into
Hospital
Surgery Center
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Kidney Cancer Diagnosis Market Share Analysis
Kidney Cancer Diagnosis market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Kidney Cancer Diagnosis business, the date to enter into the Kidney Cancer Diagnosis market, Kidney Cancer Diagnosis product introduction, recent developments, etc.
The major vendors covered:
Myriad Genetics Inc.
NeoGenomics Laboratories
Thermo Fisher Scientific Inc.
Sysmex Corporation
Rosetta Genomics
Illumina Inc.
Abbott Laboratories
Roche Holding AG